Additionally, IL-6 might upregulate the expression of an anti-atherosclerosis molecule PON1 gene at a transcriptional level through the AKT/IKK/NF-κB activation pathway in human hepatocyte-derived HepG2 cells [130]. Here, PON1 is linked to atherosclerosis.